Frequently Asked Questions

Everything you need to know about DOT and Non-DOT drug testing. Can't find your answer? Contact us directly.

General Drug Testing

DOT drug testing is federally mandated under 49 CFR Part 40 for safety-sensitive employees in transportation industries (trucking, airlines, railroads, transit, pipelines). It uses a strictly defined 5-panel urine test and requires Medical Review Officer (MRO) review of all non-negative results.

Non-DOT testing is governed by employer policy and state law, not federal regulation. It offers much greater flexibility: employers can choose from 5-, 10-, or 12-panel options and define their own testing circumstances and consequences.
Negative results are typically reported within 24 hours of the laboratory receiving the specimen.

Non-negative results require additional GC/MS confirmation testing and MRO review, which typically takes an additional 24–48 hours β€” so approximately 48–72 hours total for confirmed results.
The DOT standard 5-panel tests for: Marijuana (THC), Cocaine, Opioids, Amphetamines, and PCP.

Non-DOT tests can be expanded to include additional substances such as benzodiazepines, barbiturates, methadone, oxycodone, and more. Employers choose the panel that best fits their needs and industry.
You must bring a valid government-issued photo ID β€” such as a driver's license, state ID card, or passport. If you are being tested for employment purposes, you may also need to provide an authorization form or reference number from your employer.
Detection windows vary by substance and frequency of use. General estimates:

Marijuana: Occasional use β€” 3–4 days; heavy/chronic use β€” up to 30 days
Cocaine: 2–4 days
Opioids: 2–4 days (heroin, morphine); extended-release formulations may be longer
Amphetamines: 1–3 days
PCP: 7–14 days
Benzodiazepines: 1–7 days (varies significantly by compound)

These are general estimates. Individual metabolism, hydration, body mass, and test cutoff levels all affect results.

DOT Drug Testing Questions

DOT testing is required for employees in safety-sensitive positions within DOT-regulated industries. This includes:

β€’ Commercial truck and bus drivers (FMCSA)
β€’ Airline pilots, flight crew, air traffic controllers, and maintenance (FAA)
β€’ Railroad workers in safety-sensitive roles (FRA)
β€’ Mass transit operators (FTA)
β€’ Pipeline workers in safety-sensitive functions (PHMSA)
β€’ Maritime workers on vessels with USCG certificates
If a lab reports a non-negative result, the Medical Review Officer (MRO) will contact you directly to ask if you have a legitimate medical explanation, including valid prescriptions. If you provide satisfactory documentation, the MRO may report the result as negative to your employer.

This MRO interview process is a critical protection for employees. The employer is NOT informed of your specific prescription β€” only the final verified result.
An MRO is a licensed physician with specialized knowledge in substance abuse disorders, pharmacology, and DOT drug testing regulations. Under DOT rules, all non-negative drug test results must be reviewed by an MRO before being reported to the employer.

The MRO reviews lab results, contacts donors to discuss potential legitimate explanations, and makes the final determination on what result is reported.
Chain of custody (COC) is the unbroken, documented trail of evidence tracking a specimen from collection through laboratory analysis and result reporting. Every transfer of custody, every seal, and every signature is recorded on the Federal Custody and Control Form (CCF).

Maintaining chain of custody is critical because it:
β€’ Proves the specimen tested belongs to the donor
β€’ Prevents tampering or substitution claims
β€’ Protects both employers and employees legally
β€’ Is required for all DOT testing and strongly recommended for Non-DOT testing
Under DOT regulations, all urine specimens are divided into two bottles at the time of collection β€” a primary (Bottle A) and a split (Bottle B).

The primary specimen is tested first. If the result is positive, the donor has the right to request the split specimen be tested at a second SAMHSA-certified laboratory, at the donor's expense. This provides an independent check on the initial result.

The Collection Process

The collection process typically takes about 15–20 minutes. Here's what to expect:

1. You present your photo ID and the collector verifies your identity
2. You are given a collection cup and asked to go to the restroom (observed or unobserved, per test type)
3. The collector checks the specimen temperature (must be 90°–100Β°F within 4 minutes)
4. You and the collector seal the specimen bottles with tamper-evident tape and you initial the seals
5. The Federal CCF or custody form is completed and signed by both you and the collector
6. The specimen is packaged and shipped to the certified laboratory
There are no dietary restrictions for a standard urine drug test. However:

β€’ Excessive water intake immediately before the test may result in a "dilute" specimen, which can require a retest
β€’ Medications β€” prescribed or OTC β€” may cause a non-negative result that the MRO will review. Always be prepared to disclose valid prescriptions if asked by the MRO after a non-negative
β€’ Certain foods (e.g., poppy seeds) can potentially affect opiate results β€” discuss with the MRO if relevant
An observed collection means a same-gender collector or trained observer directly watches the donor provide the urine specimen. Under DOT rules, direct observation is required in specific circumstances:

β€’ Return-to-duty and follow-up testing
β€’ When the collector has reason to believe a donor has attempted to substitute or tamper with the specimen
β€’ When a previous specimen was reported invalid

Observed collections are not the default for standard DOT pre-employment or random testing.
If you cannot provide the minimum required specimen volume (45 mL for DOT), you will be given up to three hours and up to 40 oz of water to try again. If you still cannot provide an adequate specimen, this is classified as a "shy bladder" situation.

For DOT tests, a shy bladder referral requires the donor to be evaluated by a physician to determine if a medical condition explains the inability. Without a valid medical explanation, it is treated as a refusal to test β€” which has the same consequence as a positive result.

Employer Questions

Yes, absolutely. Before conducting any drug testing, employers must have a written drug and alcohol testing policy that is distributed to all employees. For DOT-regulated employers, specific policy elements are required by regulation. For Non-DOT employers, the policy must clearly state:

β€’ Which employees are subject to testing
β€’ When testing will occur (pre-employment, random, etc.)
β€’ What substances are tested
β€’ Consequences of a positive result or refusal to test
β€’ Employee assistance program (EAP) information

We can help guide you on policy requirements. Consult with legal counsel for state-specific requirements.
We understand that post-accident testing has strict time constraints. Under DOT regulations, urine testing must be completed as soon as possible following an accident. Call us immediately after an incident β€” we will prioritize your collection and expedite processing.

For Non-DOT employers, your policy should define the time frame for post-accident testing. We recommend testing within 2 hours of the incident. After 8 hours, document why testing did not occur and cease the attempt.

We're Here to Answer Your Questions

Our team is available Monday through Friday, 8:00am – 6:00pm to answer compliance questions and help you schedule testing.